Description
INTRAVENOUS SOLUTIONS AND LACTED RINGERS FOR VAPBM.
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-06-10+$502,869= $502,869
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-06-10 | +$502,869 | $502,869 | INTRAVENOUS SOLUTIONS AND LACTED RINGERS FOR VAPBM. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RSKLEFCZ6127)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626P0776 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $22,990 | FY2026 |
| 36C26226N0708 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $387,926 | FY2026 |
| 36C26226D0102 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026P0469 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $114,588 | FY2026 |
| 36C24826N0573 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $30,000 | FY2026 |
| 36C24826A0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 69D-NETWORK CONTRACT OFFICE 12 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA69D16F2903 | CSL BEHRING L.L.C. | 69D-NETWORK CONTRACT OFFICE 12 | $5,443 | FY2016 |
| VA69D16F2824 | SANOFI VACCINES US INC. | 69D-NETWORK CONTRACT OFFICE 12 | $53,837 | FY2016 |
| VA69D16F2660 | SEQIRUS USA INC | 69D-NETWORK CONTRACT OFFICE 12 | $125,000 | FY2016 |
| VA69D16F2687 | SEQIRUS USA INC | 69D-NETWORK CONTRACT OFFICE 12 | $54,563 | FY2016 |
| VA69D16F2665 | GRIFOLS THERAPEUTICS LLC | 69D-NETWORK CONTRACT OFFICE 12 | $5,386 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA69D14F3360_3600_VA797P12C0033_3600 · retrieved 2026-09-26.